Search results
From Self-sufficiency
- |Ship country=US ===Deepfreeze IV===19 KB (2,719 words) - 21:51, 2 July 2010
- | routes_of_administration = Oral, [[Intravenous therapy|IV]], [[Intramuscular injection|IM]], [[Subcutaneous injection|SC]] and [[Intr ...in High Mountain Environments. A Handbook for Medical Officers |publisher=US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine18 KB (2,498 words) - 16:41, 27 September 2010
- | legal_status = Schedule 4 ([[Australia|Aus]])<br />[[Over-the-counter substance|OTC]] or [[Prescrip | routes_of_administration= inhalation, [[IV]], oral28 KB (3,682 words) - 16:42, 27 September 2010
- | routes_of_administration = Endotracheal, intranasal, [[Intravenous therapy|IV]], [[Intramuscular|IM]] | onset = 2 min (IV), 5 min (IM)<ref name=AHFS2015/>33 KB (4,541 words) - 10:57, 17 June 2016
- | legal_US = Schedule IV ...in subsequent years. Guidance was issued in June 2006 of plans to enforce US approval for unapproved drugs.<ref>{{cite web| author=Michelle Meadows |tit20 KB (2,657 words) - 16:42, 27 September 2010
- | routes_of_administration = Oral, [[intravenous|IV]], topical ...bsp;mg/kg/d. A loading dose will be indicated when entering a daily dosage schedule; for example, a loading dose of 200 mg on the first day is commonly us11 KB (1,533 words) - 16:44, 27 September 2010
- | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> ...for a one-month supply. As off 2007, annual cost in India is US$1,344, and US$528 in Africa. It was approved by the U.S. [[Food and Drug Administration|F6 KB (773 words) - 16:45, 27 September 2010
- | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->3 KB (375 words) - 15:07, 6 July 2010
- | legal_CA = Schedule I | legal_US = Schedule II40 KB (5,581 words) - 16:45, 27 September 2010
- | legal_CA = Schedule I | legal_US = Schedule III69 KB (9,697 words) - 21:01, 24 September 2010
- | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | routes_of_administration = oral, [[intravenous|iv]]7 KB (895 words) - 16:48, 27 September 2010
- | bioavailability = ~25% (oral); 100% (IV); | legal_CA = Schedule I87 KB (12,376 words) - 16:51, 27 September 2010
- | legal_CA = Schedule VI | routes_of_administration = oral, [[intravenous|IV]], [[intramuscular|IM]], [[subcutaneous|SC]]21 KB (2,906 words) - 16:51, 27 September 2010
- |legal_CA=Schedule IV |legal_US =Schedule IV45 KB (6,129 words) - 22:16, 19 September 2010
- | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->1 KB (187 words) - 09:44, 20 September 2010
- ...%3F+Potential+Health+Benefits,+Savings,+and+Costs%22&hl=en&ct=clnk&cd=5&gl=us], Retrieved February 19, 2008</ref> If savings are allocated using the curr ...%3F+Potential+Health+Benefits,+Savings,+and+Costs%22&hl=en&ct=clnk&cd=5&gl=us], Retrieved February 19, 2008</ref>57 KB (8,295 words) - 21:37, 20 September 2010
- | legal_CA = Schedule IV | legal_status = [[Schedule II]]/[[Schedule III]] ([[United States|US]])9 KB (1,128 words) - 22:04, 21 September 2010
- | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> ...s = [[Controlled Substances Act|Schedule I and III]] ([[United States|US]])50 KB (6,686 words) - 22:09, 21 September 2010
- ...ia|Aust]])<br> Class C([[United Kingdom|UK]])<br> Cat. A[[Singapore]]}<br> Schedule III [[Germany]]} ...es_of_administration = [[sublingual]], [[intramuscular|IM]], [[intravenous|IV]], [[transdermal]], [[intranasal]]59 KB (8,561 words) - 22:13, 21 September 2010
- ...Non-Clinical use - and [[Schedule II]] - Clinical use - (UK), <br />DEA [[Schedule II]] (USA), [[S8]] (AU) ...ore troublesome side effects. At present, Jurnista (known as Exalgo in the US) is not approved in the USA. However, Exalgo is expected to receive approva38 KB (5,300 words) - 22:13, 21 September 2010
- | elimination_half-life = (IV)= 2.5 minutes <br /> Intranasal = 6.5 mins <br /> Transdermal = 7 hours (ra | legal_US = Schedule II33 KB (4,684 words) - 21:01, 24 September 2010
- | legal_US = Schedule II ...dustrial Committee of the U.S. Department of State and then brought to the US.61 KB (8,865 words) - 22:13, 21 September 2010
- ...)]].</ref><ref name="ReferenceB">[[#refMichael20080803|Michael 2008-08-03 (US Media)]].</ref> ...and pay $575 in court fees.<ref>[[#refMichael20090422|Michael 2009-04-22 (US Media)]].</ref> - See also the [[Legal status of Salvia divinorum#North Dak133 KB (18,241 words) - 22:14, 21 September 2010
- | legal_CA = Schedule III ...B ([[New Zealand|NZ]]), [[Controlled Substances Act|Schedule I and III]] (US)55 KB (7,839 words) - 21:04, 24 September 2010
- | legal_status = [[Schedule IV controlled substance|Schedule IV]](US)5 KB (676 words) - 14:36, 17 April 2016